SXI Life Sciences
7.037,32
PKT
+50,69
PKT
+0,73
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
25.06.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.06.19 | Roche buy | Deutsche Bank AG | |
14.06.19 | Alcon Neutral | BTIG Research | |
12.06.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
12.06.19 | Roche buy | Goldman Sachs Group Inc. | |
05.06.19 | Roche overweight | JP Morgan Chase & Co. | |
04.06.19 | Novartis Underweight | JP Morgan Chase & Co. | |
04.06.19 | Novartis Neutral | UBS AG | |
03.06.19 | Roche overweight | JP Morgan Chase & Co. | |
30.05.19 | Novartis Underweight | Morgan Stanley | |
29.05.19 | Roche overweight | JP Morgan Chase & Co. | |
29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
28.05.19 | Novartis Neutral | Credit Suisse Group | |
28.05.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
27.05.19 | Novartis Neutral | UBS AG | |
27.05.19 | Novartis Hold | Deutsche Bank AG | |
24.05.19 | Novartis Neutral | UBS AG | |
24.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
24.05.19 | Roche overweight | Barclays Capital | |
21.05.19 | Novartis buy | Kepler Cheuvreux | |
21.05.19 | Roche Hold | Deutsche Bank AG | |
17.05.19 | Novartis Neutral | Credit Suisse Group | |
16.05.19 | Roche buy | Goldman Sachs Group Inc. | |
16.05.19 | Novartis buy | Jefferies & Company Inc. | |
16.05.19 | Novartis Neutral | UBS AG | |
16.05.19 | Roche overweight | JP Morgan Chase & Co. | |
09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
08.05.19 | Roche overweight | JP Morgan Chase & Co. | |
07.05.19 | Novartis Hold | Deutsche Bank AG | |
07.05.19 | Roche Reduce | Oddo BHF | |
06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
30.04.19 | Roche overweight | Morgan Stanley | |
25.04.19 | Novartis Neutral | Credit Suisse Group | |
25.04.19 | Novartis Hold | Deutsche Bank AG | |
25.04.19 | Novartis Hold | HSBC | |
25.04.19 | Novartis buy | Jefferies & Company Inc. | |
25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
24.04.19 | Novartis Neutral | UBS AG | |
24.04.19 | Alcon buy | Goldman Sachs Group Inc. |